Related Experiment Video
Updated: Jun 7, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
High-throughput screening identifies paullinic acid as an antiviral agent against Bombyx mori nucleopolyhedrovirus
Zhenwei Jia1, Xiaoli Mo1, Shidong Jiang2
1Jiangsu Key Laboratory of Sericultural and Animal Biotechnology, School of Biotechnology, Jiangsu University of Science and Technology, Zhenjiang 212100, China.
Abstract:
Bombyx mori nucleopolyhedrovirus (BmNPV) is a crucial pathogenic agent causing significant harm to sericulture industry, and currently, there are no therapeutic drugs available for the diseases caused by it. his study established a BmNPV-eGFP-based high-throughput screening platform to identify antiviral compounds against BmNPV. Screening 235 natural products revealed paullinic acid as a potent inhibitor, reducing viral replication without cytotoxicity. Mechanistic studies demonstrated that paullinic acid suppressed BmNPV proliferation by disrupting lipid homeostasis, significantly lowering intracellular triacylglycerol (TAG), free fatty acids (FFA), and cholesterol (CHO) levels-key factors facilitating viral replication. Crucially, Paullinia cupana extract (rich in paullinic acid) exhibited comparable antiviral effects in vivo, increasing survival rates by 45 % in BmNPV-infected silkworms. Additional screening identified cyclosporin A and 1-methylinosine, and Fenofibrate as potential inhibitors. These findings validate natural products as promising sources for anti-BmNPV therapeutics and highlight lipid modulation as a novel antiviral strategy for sericulture industry.
Insights
Paullinic acid from natural products inhibits Bombyx mori nucleopolyhedrovirus (BmNPV) by disrupting lipid homeostasis. This discovery offers a new therapeutic strategy for the sericulture industry, increasing silkworm survival rates.
Area of Science:
- Virology
- Natural Product Chemistry
- Biochemistry
Background:
- Bombyx mori nucleopolyhedrovirus (BmNPV) severely impacts the sericulture industry.
- No effective antiviral drugs currently exist for BmNPV infections.
Purpose of the Study:
- To establish a high-throughput screening platform for identifying BmNPV antiviral compounds.
- To discover novel therapeutic agents from natural products against BmNPV.
Main Methods:
- Developed a BmNPV-eGFP-based high-throughput screening platform.
- Screened 235 natural products for antiviral activity.
- Conducted mechanistic studies on identified inhibitors, including lipid analysis.
- Evaluated the efficacy of Paullinia cupana extract in vivo.
Main Results:
- Identified paullinic acid as a potent BmNPV inhibitor, reducing viral replication without cytotoxicity.
- Paullinic acid disrupted lipid homeostasis by lowering triacylglycerol, free fatty acids, and cholesterol.
- Paullinia cupana extract significantly increased survival rates in BmNPV-infected silkworms.
- Cyclosporin A, 1-methylinosine, and Fenofibrate were also identified as potential inhibitors.
Conclusions:
- Natural products represent a promising source for developing anti-BmNPV therapeutics.
- Lipid modulation is a novel and effective antiviral strategy for BmNPV.
- This study provides a foundation for new treatments in the sericulture industry.
Related Concept Videos
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly

